Loading...
•
Jun 30, 2025
Xylem Q2 2025 Earnings Report
Xylem posted strong Q2 2025 results with double-digit EPS growth and raised full-year guidance.
Key Takeaways
Xylem exceeded expectations in Q2 2025, delivering strong organic revenue growth, record-high adjusted EBITDA margin, and increased EPS. The company raised its full-year guidance due to robust demand and disciplined execution.
Delivered revenue of $2.3 billion with solid growth across all segments
Reported EPS of $0.93 and adjusted EPS of $1.26
Net income reached $226 million, up from $194 million last year
Raised full-year revenue and adjusted EPS guidance
Revenue by Segment
Forward Guidance
Xylem raised its full-year 2025 outlook for revenue and adjusted EPS based on resilient demand and strong operational execution.
Positive Outlook
- Full-year revenue now guided to $8.9–$9.0 billion, up from prior $8.7–$8.8 billion
- Adjusted EPS raised to $4.70–$4.85 from $4.50–$4.70
- Expected adjusted EBITDA margin of 21.3% to 21.8%
- Full-year organic revenue growth of approximately 4%
- Maintains free cash flow margin outlook of 9–10%
Challenges Ahead
- Ongoing macroeconomic and geopolitical uncertainties
- Risks from inflation and supply chain pressures
- Possible delays in receiving parts and raw materials
- Challenges related to integration of Evoqua acquisition
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...